Lung cancer and proton therapyThe lungs are adjacent to some of the most sensitive and important organs and tissues, including the heart, esophagus, and spinal cord. Only about 20% of lung tumors can be treated by surgery; other ..
Lung cancer is one of the most common causes of human death due to tumors, and its morbidity and mortality rate have ranked first in cities. The pathology is mainly non-small cell lung cancer (NSCLC), accounting for about 85%. M..
The results of the LUX-Lung 7 study show that a head-to-head Phase IIb clinical study compared afatinib and gefitinib in the treatment of tumors with EGFR mutations The results are published in the "Lancet Oncology" magazine.Chief..
The second edition of the 2016 NCCN Guidelines for Small Cell Lung Cancer (V2.2016) mainly updates the following parts based on V2.2015:Lung cancer preliminary assessment stage updateSCL-2: Some patients can be selected for bone m..
Registration: ClinicalTrials.govLast updated: January 25, 2016Main ID: NCT02659059Registration Date: January 15, 2016Main sponsor: Bristol-Myers SquibbOpen topic: Nivolumab plus Ipilimumab as a first-line treatment for stage IV no..
The US FDA today approved the official launch of AstraZeneca's new drug AZD9291! The trade name and common name of AZD9291 are called Tagrisso or Osimertinib. This is the third generation of TKI targeted drugs for the treatment ..
Lung cancer problemPerhaps it is because of the direct feeling of the respiratory system. As the haze continues, we feel more and more people suffering from lung cancer around us. Indeed, lung cancer is the fastest growing malign..
The US Food and Drug Administration (hereinafter referred to as FDA) approved Portrazza (necitumumab) in combination with gemcitabine and cisplatin in the treatment of advanced (metastatic) squamous non-small cell lung cancer on N..
MPDL3280A, which retains the PD-L2 / PD-1 interaction, potentially reduces autoimmune lung toxicity, and has a good effect on advanced NSCLC. Platinum-based chemotherapy is still the standard first-line treatment for non-small ce..
Treatment of non-small cell lung cancerThe treatment of lung cancer mainly uses surgery, radiotherapy and chemotherapy, and surgery is still the most effective method for the treatment of lung cancer in the early and middle stages..